ArticleInternational journal of molecular sciences2022

Homozygous CRISPR/Cas9 Knockout Generated a Novel Functionally Active Exon 1 Skipping XPA Variant in Melanoma Cells.

Veronika Banicka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.